Tokyo Tape
Sign in
← Fukuda Denshi

Annual report

6960.TEDINET S100TU7S
Period2023-04-01 → 2024-03-31
Filed2024-06-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥140.3bn2023-04-01 → 2024-03-31Cons.Net sales
Revenue¥134.6bn2022-04-01 → 2023-03-31Cons.Net sales
Revenue¥132.1bn2021-04-01 → 2022-03-31dCons.Net sales (5-year summary)
Revenue¥146.8bn2020-04-01 → 2021-03-31dCons.Net sales (5-year summary)
Revenue¥133.4bn2019-04-01 → 2020-03-31dCons.Net sales (5-year summary)
Operating income¥26.5bn2023-04-01 → 2024-03-31Cons.Operating income
Operating income¥24.1bn2022-04-01 → 2023-03-31Cons.Operating income
Ordinary income¥27.0bn2023-04-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥25.1bn2022-04-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥23.4bn2021-04-01 → 2022-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥20.3bn2020-04-01 → 2021-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥13.6bn2019-04-01 → 2020-03-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥27.0bn2023-04-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥25.2bn2022-04-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥18.7bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥17.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥16.2bn2021-04-01 → 2022-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥14.7bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥9.6bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥18.7bn2023-04-01 → 2024-03-31Cons.Profit loss
Net income¥17.3bn2022-04-01 → 2023-03-31Cons.Profit loss
Total assets¥209.1bnat 2024-03-31Cons.Assets
Total assets¥206.9bnat 2023-03-31Cons.Assets
Total assets¥195.5bnat 2022-03-31dCons.Total assets (5-year summary)
Total assets¥191.8bnat 2021-03-31dCons.Total assets (5-year summary)
Total assets¥168.7bnat 2020-03-31dCons.Total assets (5-year summary)
Total liabilities¥40.1bnat 2024-03-31Cons.Liabilities
Total liabilities¥43.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥169.0bnat 2024-03-31Cons.Net assets
Net assets / equity¥163.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥149.9bnat 2022-03-31dCons.Net assets
Net assets / equity¥138.0bnat 2021-03-31dCons.Net assets (5-year summary)
Net assets / equity¥124.4bnat 2020-03-31dCons.Net assets (5-year summary)
Cash and deposits¥60.2bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥68.0bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥57.2bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥64.9bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥61.0bnat 2022-03-31dCons.Cash and cash equivalents
Cash & equivalents¥53.6bnat 2021-03-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥46.1bnat 2020-03-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥23.9bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥23.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥23.1bn2021-04-01 → 2022-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥21.7bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥20.2bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥14.8bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥14.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.8bn2021-04-01 → 2022-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥11.3bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥14.2bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥17.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥4.8bn2021-04-01 → 2022-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.0bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥3.7bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥622.442023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥571.252022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥536.192021-04-01 → 2022-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥486.672020-04-01 → 2021-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥316.522019-04-01 → 2020-03-31dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥5,863.22at 2024-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥5,390.09at 2023-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥4,954.7at 2022-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥4,562.94at 2021-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥4,114.98at 2020-03-31dCons.Net assets per share (5-year summary)
Equity ratio80.8%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio76.7%at 2022-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio72.0%at 2021-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2020-03-31dCons.Equity to asset ratio (5-year summary)
ROE11.3%2023-04-01 → 2024-03-31Cons.Rate of return on equity (5-year summary)
ROE11.0%2022-04-01 → 2023-03-31Cons.Rate of return on equity (5-year summary)
ROE11.3%2021-04-01 → 2022-03-31dCons.Rate of return on equity (5-year summary)
ROE11.2%2020-04-01 → 2021-03-31dCons.Rate of return on equity (5-year summary)
ROE7.9%2019-04-01 → 2020-03-31dCons.Rate of return on equity (5-year summary)
Employees3,443at 2024-03-31Cons.Number of employees
Employees3,382at 2023-03-31Cons.Number of employees
Employees3,348at 2022-03-31dCons.Number of employees
Employees3,291at 2021-03-31dCons.Number of employees
Employees3,208at 2020-03-31dCons.Number of employees
Revenue¥87.0bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥82.3bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥82.5bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥81.8bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥71.8bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Operating income¥14.5bn2023-04-01 → 2024-03-31StandaloneOperating income
Operating income¥12.4bn2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income¥21.2bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥18.5bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥18.0bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥15.0bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥9.9bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥21.4bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax¥18.7bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income¥17.1bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income¥14.8bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥14.4bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income¥12.0bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥8.0bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥177.6bnat 2024-03-31StandaloneAssets
Total assets¥176.0bnat 2023-03-31StandaloneAssets
Total assets¥163.5bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥158.1bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥137.3bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥46.9bnat 2024-03-31StandaloneLiabilities
Total liabilities¥48.8bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥130.7bnat 2024-03-31StandaloneNet assets
Net assets / equity¥127.2bnat 2023-03-31StandaloneNet assets
Net assets / equity¥117.1bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥107.2bnat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥96.7bnat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥37.9bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥46.1bnat 2023-03-31StandaloneCash and deposits
EPS (basic)¥567.962023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥489.272022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥477.62021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥397.012020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥264.82019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥1852023-04-01 → 2024-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥2402022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥3052021-04-01 → 2022-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥2752020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥1802019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥4,534.7at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,204.87at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥3,871.21at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥3,543.95at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥3,199.28at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio73.6%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.3%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.6%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio67.8%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio70.4%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE13.2%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE12.1%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE12.9%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE11.8%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE8.5%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued37,747,000at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued39,176,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued19,588,000at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued19,588,000at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued19,588,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees699at 2024-03-31StandaloneNumber of employees
Employees690at 2023-03-31StandaloneNumber of employees
Employees669at 2022-03-31dStandaloneNumber of employees
Employees659at 2021-03-31dStandaloneNumber of employees
Employees651at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 64
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment assetsat 2024-03-31¥97.2bn
Consumables And Other Productsreportable segmentcapex2023-04-01 → 2024-03-31¥1.6bn
Consumables And Other Productsreportable segmentdepreciation2023-04-01 → 2024-03-31¥757m
Consumables And Other Productsreportable segmentrevenue2023-04-01 → 2024-03-31¥40.2bn
Consumables And Other Productsreportable segmentrevenue external2023-04-01 → 2024-03-31¥40.2bn
Consumables And Other Productsreportable segmentsegment assetsat 2024-03-31¥27.3bn
Consumables And Other Productsreportable segmentsegment profit2023-04-01 → 2024-03-31¥6.9bn
Medical Treatment Equipmentreportable segmentcapex2023-04-01 → 2024-03-31¥11.7bn
Medical Treatment Equipmentreportable segmentdepreciation2023-04-01 → 2024-03-31¥8.2bn
Medical Treatment Equipmentreportable segmentrevenue2023-04-01 → 2024-03-31¥59.7bn
Medical Treatment Equipmentreportable segmentrevenue external2023-04-01 → 2024-03-31¥59.7bn
Medical Treatment Equipmentreportable segmentsegment assetsat 2024-03-31¥56.0bn
Medical Treatment Equipmentreportable segmentsegment profit2023-04-01 → 2024-03-31¥12.8bn
Patient Monitoring Equipmentreportable segmentcapex2023-04-01 → 2024-03-31¥384m
Patient Monitoring Equipmentreportable segmentdepreciation2023-04-01 → 2024-03-31¥182m
Patient Monitoring Equipmentreportable segmentrevenue2023-04-01 → 2024-03-31¥9.7bn
Patient Monitoring Equipmentreportable segmentrevenue external2023-04-01 → 2024-03-31¥9.7bn
Patient Monitoring Equipmentreportable segmentsegment assetsat 2024-03-31¥7.6bn
Patient Monitoring Equipmentreportable segmentsegment profit2023-04-01 → 2024-03-31¥1.7bn
Physiological Diagnostic Equipmentreportable segmentcapex2023-04-01 → 2024-03-31¥1.2bn
Physiological Diagnostic Equipmentreportable segmentdepreciation2023-04-01 → 2024-03-31¥577m
Physiological Diagnostic Equipmentreportable segmentrevenue2023-04-01 → 2024-03-31¥30.7bn
Physiological Diagnostic Equipmentreportable segmentrevenue external2023-04-01 → 2024-03-31¥30.7bn
Physiological Diagnostic Equipmentreportable segmentsegment assetsat 2024-03-31¥21.1bn
Physiological Diagnostic Equipmentreportable segmentsegment profit2023-04-01 → 2024-03-31¥5.1bn
—segment totalemployeesat 2024-03-312740 pure
Total Of Reportable Segments And Otherssegment totalcapex2023-04-01 → 2024-03-31¥14.9bn
Total Of Reportable Segments And Otherssegment totaldepreciation2023-04-01 → 2024-03-31¥9.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2024-03-31¥140.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2024-03-31¥140.3bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-03-31¥111.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2024-03-31¥26.5bn
Reconciling Itemsreconcilingsegment assetsat 2023-03-31¥100.1bn
Consumables And Other Productsreportable segmentcapex2022-04-01 → 2023-03-31¥1.3bn
Consumables And Other Productsreportable segmentdepreciation2022-04-01 → 2023-03-31¥699m
Consumables And Other Productsreportable segmentrevenue2022-04-01 → 2023-03-31¥36.5bn
Consumables And Other Productsreportable segmentrevenue external2022-04-01 → 2023-03-31¥36.5bn
Consumables And Other Productsreportable segmentsegment assetsat 2023-03-31¥25.7bn
Consumables And Other Productsreportable segmentsegment profit2022-04-01 → 2023-03-31¥4.7bn
Medical Treatment Equipmentreportable segmentcapex2022-04-01 → 2023-03-31¥8.3bn
Medical Treatment Equipmentreportable segmentdepreciation2022-04-01 → 2023-03-31¥7.9bn
Medical Treatment Equipmentreportable segmentrevenue2022-04-01 → 2023-03-31¥55.4bn
Medical Treatment Equipmentreportable segmentrevenue external2022-04-01 → 2023-03-31¥55.4bn
Medical Treatment Equipmentreportable segmentsegment assetsat 2023-03-31¥50.7bn
Medical Treatment Equipmentreportable segmentsegment profit2022-04-01 → 2023-03-31¥12.4bn
Patient Monitoring Equipmentreportable segmentcapex2022-04-01 → 2023-03-31¥417m
Patient Monitoring Equipmentreportable segmentdepreciation2022-04-01 → 2023-03-31¥222m
Patient Monitoring Equipmentreportable segmentrevenue2022-04-01 → 2023-03-31¥11.6bn
Patient Monitoring Equipmentreportable segmentrevenue external2022-04-01 → 2023-03-31¥11.6bn
Patient Monitoring Equipmentreportable segmentsegment assetsat 2023-03-31¥8.7bn
Patient Monitoring Equipmentreportable segmentsegment profit2022-04-01 → 2023-03-31¥2.1bn
Physiological Diagnostic Equipmentreportable segmentcapex2022-04-01 → 2023-03-31¥1.1bn
Physiological Diagnostic Equipmentreportable segmentdepreciation2022-04-01 → 2023-03-31¥594m
Physiological Diagnostic Equipmentreportable segmentrevenue2022-04-01 → 2023-03-31¥31.1bn
Physiological Diagnostic Equipmentreportable segmentrevenue external2022-04-01 → 2023-03-31¥31.1bn
Physiological Diagnostic Equipmentreportable segmentsegment assetsat 2023-03-31¥21.7bn
Physiological Diagnostic Equipmentreportable segmentsegment profit2022-04-01 → 2023-03-31¥4.9bn
Total Of Reportable Segments And Otherssegment totalcapex2022-04-01 → 2023-03-31¥11.1bn
Total Of Reportable Segments And Otherssegment totaldepreciation2022-04-01 → 2023-03-31¥9.4bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2023-03-31¥134.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2023-03-31¥134.6bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-03-31¥106.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2023-03-31¥24.1bn
—segment totalemployeesat 2024-03-31591 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,684
ItemContextValueUnit
Lease obligations nclCurrentYearInstant_NonConsolidatedMember73000000JPY
Provision for share based remuneration for directors and other officers nclPrior1YearInstant_NonConsolidatedMember214000000JPY
Provision for share based remuneration for directors and other officers nclCurrentYearInstant_NonConsolidatedMember249000000JPY
Provision for employee stock ownership plan trustPrior1YearInstant_NonConsolidatedMember334000000JPY
Provision for employee stock ownership plan trustCurrentYearInstant_NonConsolidatedMember358000000JPY
Provision for retirement benefitsPrior1YearInstant_NonConsolidatedMember666000000JPY
Provision for retirement benefitsCurrentYearInstant_NonConsolidatedMember681000000JPY
Long term accounts payable otherPrior1YearInstant_NonConsolidatedMember812000000JPY
Long term accounts payable otherCurrentYearInstant_NonConsolidatedMember812000000JPY
Other nclPrior1YearInstant_NonConsolidatedMember142000000JPY
Other nclCurrentYearInstant_NonConsolidatedMember182000000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember2275000000JPY
Noncurrent liabilitiesCurrentYearInstant_NonConsolidatedMember2359000000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember48775000000JPY
LiabilitiesCurrentYearInstant_NonConsolidatedMember46877000000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember4621000000JPY
Capital stockCurrentYearInstant_NonConsolidatedMember4621000000JPY
Legal capital surplusPrior1YearInstant_NonConsolidatedMember8946000000JPY
Legal capital surplusCurrentYearInstant_NonConsolidatedMember8946000000JPY
Other capital surplusPrior1YearInstant_NonConsolidatedMember12939000000JPY
Other capital surplusCurrentYearInstant_NonConsolidatedMember8557000000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember21886000000JPY
Capital surplusCurrentYearInstant_NonConsolidatedMember17503000000JPY
Legal retained earningsPrior1YearInstant_NonConsolidatedMember1171000000JPY
Legal retained earningsCurrentYearInstant_NonConsolidatedMember1171000000JPY
Reserve for business expansionPrior1YearInstant_NonConsolidatedMember300000000JPY
Reserve for business expansionCurrentYearInstant_NonConsolidatedMember300000000JPY
Reserve for advanced depreciation of noncurrent assetsPrior1YearInstant_NonConsolidatedMember53000000JPY
Reserve for advanced depreciation of noncurrent assetsCurrentYearInstant_NonConsolidatedMember53000000JPY
General reservePrior1YearInstant_NonConsolidatedMember37500000000JPY
General reserveCurrentYearInstant_NonConsolidatedMember37500000000JPY
Retained earnings brought forwardPrior1YearInstant_NonConsolidatedMember79680000000JPY
Retained earnings brought forwardCurrentYearInstant_NonConsolidatedMember91247000000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember118705000000JPY
Retained earningsCurrentYearInstant_NonConsolidatedMember130272000000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-20412000000JPY
Treasury stockCurrentYearInstant_NonConsolidatedMember-27277000000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember124801000000JPY
Shareholders equityCurrentYearInstant_NonConsolidatedMember125119000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember2394000000JPY
Valuation difference on available for sale securitiesCurrentYearInstant_NonConsolidatedMember5593000000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember2394000000JPY
Valuation and translation adjustmentsCurrentYearInstant_NonConsolidatedMember5593000000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember127195000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember130713000000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember175970000000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember177590000000JPY
Net salesPrior1YearDuration_NonConsolidatedMember82316000000JPY
Net salesCurrentYearDuration_NonConsolidatedMember86987000000JPY
Cost of salesPrior1YearDuration_NonConsolidatedMember54037000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2024-03-31pass
balance sheet identitynon_consolidated 2023-03-31pass
balance sheet identitynon_consolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass